 Actinium Pharmaceuticals Inc AMEX:ATNM shares are trading higher Tuesday morning after the company announced it entered into a license and supply agreement with Immedica Pharma for Iomab-B. Actinium will receive an upfront payment of 35 million and will be eligible for . 